Smoflipid Injection, Emulsion
Product Images NDC 63323-820

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Smoflipid (NDC 63323-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Smo00 0005 01

Smoflipid intravenous injection emulsion in a flexible plastic bag with two ports at the bottom, labeled 'A' and 'H' for administration connections. The bag is clear with no visible printed text, used for parenteral nutrition. The product is manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Smo00 0005 02

An instructional illustration showing two hands manipulating a bag or pouch. One hand grips the top corners, appearing to open or hold the bag, with arrows pointing to two labeled points at the bottom labeled "A" and "B." This likely demonstrates preparation or hanging instructions for an intravenous emulsion product.*

FDA Label Image

Smo00 0005 03

An instructional illustration showing a hand opening or preparing a vial or small bottle, likely demonstrating how to use or access the intravenous injection emulsion Smoflipid by Fresenius Kabi USA, LLC.*

FDA Label Image

Smo00 0005 04

An instructional illustration showing a hand inserting a needle into a vial or port, possibly demonstrating preparation or withdrawal of Smoflipid intravenous emulsion injection.*

FDA Label Image

Smo00 0005 05

Smoflipid intravenous injection emulsion in a flexible plastic bag with a port and tubing connectors. The image shows the clear bag without a visible label text but indicates a parenteral product suitable for intravenous administration. The container is typical for infusion bags used in hospital settings.*

FDA Label Image

Smo00 0005 06

A cumulative incidence function graph comparing Soybean Oil and SMOFlipid over 84 study days. The graph shows the number of subjects with events and censored for each group, with Soybean Oil having higher cumulative incidence values than SMOFlipid. Data points with error bars and censoring indicators are included, along with patient counts at risk over time for both groups.*

FDA Label Image

Smo00 0005 07

Chemical structure diagram of Smoflipid showing its molecular composition with multiple ester and carbonyl functional groups arranged in a complex lipid emulsion format.*

FDA Label Image

Smo00 0005 08

Chemical structure diagram depicting a molecular formula with several rings and functional groups, representing the active ingredient of Smoflipid injection emulsion by Fresenius Kabi USA, LLC.*

FDA Label Image

Smo00 0005 09

Chemical structure of Smoflipid active ingredients. The diagram shows molecular components typical of lipid emulsions used in intravenous injections, illustrating bonds and atoms without specific labeling of elements.*

FDA Label Image

Smo00 0005 10

Chemical structure of Smoflipid, displayed as a molecular diagram showcasing the arrangement of atoms and bonds within the active ingredient. The image highlights the molecular components relevant to this intravenous injection emulsion product by Fresenius Kabi USA, LLC.*

FDA Label Image

Smo00 0005 11

Chemical structure of the active ingredient in Smoflipid injection, emulsion, depicting a complex lipid molecule with multiple carbon chains, double bonds, and a terminal carboxylic acid group.*

FDA Label Image

Smo00 0005 12

Chemical structure diagram of Smoflipid, showing its molecular formula with carbon, hydrogen, and oxygen atoms arranged to depict the emulsion's composition.*

FDA Label Image

Smo00 0005 13

Chemical structure diagram showing the molecular formula of Smoflipid, an intravenous injection emulsion by Fresenius Kabi USA, LLC. The illustration depicts the arrangement of atoms and bonds characteristic of the active ingredients in Smoflipid.*

FDA Label Image

Smo00 0005 14

Chemical structure diagram of Smoflipid, displaying its molecular components and bonds consistent with the injected emulsion form used intravenously.*

FDA Label Image

Smo00 0005 15

Chemical structure diagram of the active ingredient Smoflipid, an intravenous lipid emulsion used in human prescription drugs. The structure depicts a long-chain fatty acid molecule with hydrocarbon chains and a carboxyl group.*

FDA Label Image

Smo00 0005 16

Chemical structure diagram of Smoflipid, showing its molecular components and arrangement as a lipid emulsion active ingredient.*

FDA Label Image

Smo00 0005 17

Chemical structure of Smoflipid, shown as a detailed molecular diagram with carbon chains, double bonds, and functional groups indicative of the lipid emulsion's chemical composition.*

FDA Label Image

Smo00 0005 18

Chemical structure of Smoflipid, an intravenous injection emulsion, showing the molecular configuration of its active components.*

FDA Label Image

Smo00 0005 19

Chemical structure of Smoflipid, an intravenous injection emulsion. The diagram shows the detailed molecular arrangement consistent with the active ingredient in Smoflipid by Fresenius Kabi USA, LLC.*

FDA Label Image

Smo00 0005 20

FDA Label Image

Smo00 0005 21

Smoflipid 20% lipid injectable emulsion, 20 grams per 100 mL intravenous infusion by Fresenius Kabi USA, LLC. The label details contents including soybean oil 6 g, medium chain triglycerides 6 g, olive oil 5 g, and fish oil 3 g per 100 mL. Additional components and storage instructions are included, along with manufacturer information from Uppsala, Sweden.*

FDA Label Image

Smo00 0005 22

Smoflipid 20% lipid injectable emulsion, USP, 20 grams per 100 mL (0.2 grams/mL) for intravenous use. The 100 mL container includes 6 g soybean oil USP, 6 g medium chain triglycerides NF, 5 g olive oil NF, and 3 g fish oil USP per 100 mL. Manufactured by Fresenius Kabi USA, LLC in Uppsala, Sweden, the label advises storage below 25°C, protection from freezing, and use within 24 hours after opening. Contains warnings against making additions and instructions for infusion port use.*

FDA Label Image

Smo00 0005 23

Smoflipid 20% lipid injectable emulsion, 50 grams per 250 mL (0.2 grams/mL) intravenous injection. The 250 mL bag contains 6 g soybean oil, 6 g medium chain triglycerides, 5 g olive oil, and 3 g fish oil per 100 mL. Manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. Label includes storage instructions and use warnings.*

FDA Label Image

Smo00 0005 24

Smoflipid 20% lipid injectable emulsion label for intravenous use, 500 mL bottle containing 100 grams of lipids. Ingredients per 100 mL include soybean oil 6 g, medium chain triglycerides 6 g, olive oil 5 g, and fish oil 3 g. Manufactured by Fresenius Kabi USA, LLC in Uppsala, Sweden. The label lists storage and usage instructions, including maintaining temperature below 25°C and using within 24 hours after opening.*

FDA Label Image

Smo00 0005 25

Label for Smoflipid injection, emulsion USP 20%, containing 200 grams per 1000 mL (0.2 grams/mL). It is a pharmacy bulk package not for direct infusion, for intravenous use in 1000 mL bags. Each 100 mL contains 6 g soybean oil, 6 g medium chain triglycerides, 6 g olive oil, and 3 g fish oil. The product is manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. Storage instructions and composition details are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.